MP56-18 ARE INTERMEDIATE RISK NMIBC FAILING BCG A HIGH RISK DISEASE? LONG TERM RESULTS OF A PHASE II STUDY ON SECOND LINE INTRAVESICAL GEMCITABINE.
2014
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI